YAR047C is annotated as a dubious open reading frame (ORF) in S. cerevisiae, with genomic studies showing it is deleted in 59 of 63 surveyed yeast strains . This suggests it is non-essential under standard laboratory conditions. The recombinant form is typically expressed as a partial protein (amino acids 1–106) , likely due to challenges in purifying full-length membrane proteins .
Low Abundance: Native YAR047C is undetectable in proteomic studies, complicating functional analysis .
Expression Issues: Membrane proteins often require specialized hosts (e.g., Rhodobacter spp.) for proper folding , but YAR047C is typically produced in E. coli, risking misfolding.
Annotation Conflicts: Classified as a "dubious ORF" in genomic databases , yet recombinant versions are marketed for hypothesis-driven research .
Interaction Studies: Large-scale yeast two-hybrid screens have not yet identified binding partners for YAR047C , but targeted assays could clarify its role.
Structural Analysis: Cryo-EM or X-ray crystallography could resolve its membrane topology.
Conditional Knockout Models: Testing under stress conditions (e.g., nutrient limitation) may reveal context-dependent functions .
STRING: 4932.YAR047C
YAR047C is a putative uncharacterized membrane protein found in Saccharomyces cerevisiae (baker's yeast). The protein consists of 106 amino acids with the sequence: MYQTSPLSLFYFQVLVPKFLECFLCFPYHKISLVALLSFFYCQLQTNMIILLSQIKRFLYRQIMIALKIKAKKFWFIFKYFNVSCDARLFNELFYIFQTYVSVDSK . This protein has been assigned the UniProt ID P39557 and is classified as a membrane protein based on its hydrophobicity profile and predicted transmembrane domains. YAR047C is encoded by a gene located on chromosome I of S. cerevisiae and is expressed at relatively low levels under standard growth conditions.
Recombinant YAR047C can be produced as a full-length protein (1-106 amino acids) with fusion tags to facilitate purification and detection. Commonly, it is expressed with an N-terminal His tag, which enables efficient purification using metal affinity chromatography . The protein has multiple hydrophobic regions consistent with its classification as a membrane protein. Based on sequence analysis, YAR047C contains:
| Structural Feature | Characteristics |
|---|---|
| Protein Length | 106 amino acids |
| Molecular Weight | Approximately 12.5 kDa (without tags) |
| Isoelectric Point | Predicted to be slightly basic |
| Secondary Structure | Predicted to contain transmembrane α-helices |
| Post-translational Modifications | Potential phosphorylation sites (predicted) |
| Fusion Tags | Commonly expressed with N-terminal His tag |
The recombinant form of YAR047C is typically produced in E. coli expression systems, which provide a cost-effective and scalable approach to protein production . The production process involves:
Cloning the YAR047C gene into an appropriate expression vector with a His-tag coding sequence
Transforming the construct into a suitable E. coli strain (commonly BL21(DE3) or similar)
Inducing protein expression under optimized conditions
Cell lysis to release the protein
Purification via metal affinity chromatography using the His-tag
Additional purification steps as needed (e.g., size exclusion chromatography)
Quality control assessment including SDS-PAGE for purity evaluation
Appropriate storage of the purified protein (typically >90% purity)
Based on available data, the optimal storage conditions for recombinant YAR047C are:
Store the lyophilized powder at -20°C/-80°C upon receipt
For reconstituted protein, aliquoting is necessary to avoid repeated freeze-thaw cycles
Working aliquots can be stored at 4°C for up to one week
Long-term storage should be at -20°C/-80°C with 5-50% glycerol (50% is the default recommendation)
The recommended storage buffer is Tris/PBS-based buffer with 6% Trehalose, pH 8.0
Repeated freeze-thaw cycles should be avoided as they can lead to protein degradation and loss of activity .
While E. coli is the most commonly used expression system for YAR047C , researchers should consider multiple expression systems based on experimental requirements:
| Expression System | Advantages | Limitations | Recommended For |
|---|---|---|---|
| E. coli | - High yield - Cost-effective - Rapid production - Simple purification | - Potential folding issues - Lack of eukaryotic PTMs - Endotoxin contamination | - Structural studies - Antibody production - Initial characterization |
| Yeast (S. cerevisiae) | - Native environment - Proper folding - Basic eukaryotic PTMs | - Lower yield than E. coli - More complex purification | - Functional studies - Protein-protein interactions - Localization studies |
| Insect cells | - High-quality eukaryotic PTMs - Good for membrane proteins | - Higher cost - Technical complexity - Longer timeframe | - Detailed functional analyses - Complex structural studies |
| Cell-free systems | - Rapid production - Avoids toxicity issues | - Higher cost - Lower yield | - Quick screening - Toxic proteins |
For most basic research applications, E. coli expression using BL21(DE3) strain with a pET vector system provides sufficient quantity and quality of recombinant YAR047C .
Verification of purity and activity should follow a systematic approach:
Proper reconstitution is critical for maintaining protein activity:
Briefly centrifuge the vial containing lyophilized protein prior to opening to bring contents to the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (50% is recommended) for long-term storage
Aliquot into smaller volumes to prevent repeated freeze-thaw cycles
For membrane protein studies, consider reconstitution into lipid nanodisc or detergent micelles for stability
YAR047C represents an interesting subject for membrane protein research due to its uncharacterized nature. Advanced applications include:
Structural Biology Approaches:
X-ray crystallography (challenging for membrane proteins)
Cryo-electron microscopy for structure determination
NMR spectroscopy for dynamic studies
Molecular dynamics simulations to predict membrane interactions
Functional Characterization:
Yeast two-hybrid screening to identify interaction partners
Co-immunoprecipitation studies to validate protein interactions
Localization studies using fluorescently tagged variants
Deletion/mutation analysis to assess phenotypic effects
Comparative Analysis:
Study of homologous proteins across fungal species
Evolutionary conservation analysis to predict functional importance
Systems biology approaches to place YAR047C in cellular networks
For studying YAR047C localization in living cells, several complementary approaches are recommended:
| Technique | Methodology | Advantages | Limitations |
|---|---|---|---|
| Fluorescent Protein Fusion | Express YAR047C fused to GFP or similar fluorescent proteins | - Live cell imaging - Temporal dynamics - Relatively non-invasive | - Potential interference with function - Overexpression artifacts |
| Immunofluorescence | Fix cells and label with specific antibodies against YAR047C | - Detection of endogenous protein - High specificity | - Requires cell fixation - Potential fixation artifacts - Requires specific antibodies |
| Subcellular Fractionation | Physically separate cellular compartments and detect YAR047C by immunoblotting | - Biochemical validation - Quantitative | - Loses spatial resolution - Potential fractionation artifacts |
| Proximity Labeling | Express YAR047C fused to BioID or APEX2 | - Identifies neighboring proteins - Maps protein microenvironment | - Requires fusion proteins - Potential non-specific labeling |
| Electron Microscopy | Immunogold labeling for ultra-structural localization | - Highest spatial resolution - Contextualized in cellular ultrastructure | - Complex sample preparation - Limited to fixed samples |
A combination of these approaches provides the most reliable localization data, with particular attention to controlling for tag-induced artifacts through functional validation.
Membrane proteins like YAR047C are particularly challenging to work with. Common issues and solutions include:
Protein Aggregation:
Cause: Improper folding, detergent mismatch, concentration too high
Solution: Screen different detergents, reduce protein concentration, add stabilizers like glycerol or specific lipids
Low Expression Yield:
Cause: Toxicity to host, formation of inclusion bodies, codon bias
Solution: Use controlled expression systems, lower induction temperature, optimize codon usage for expression host
Degradation:
Cause: Protease contamination, improper storage, repeated freeze-thaw
Solution: Add protease inhibitors during purification, store with glycerol, avoid freeze-thaw cycles
Poor Solubility:
Cause: Hydrophobic nature of membrane proteins
Solution: Test different solubilization buffers, use mild detergents, consider membrane mimetics like nanodiscs
Loss of Activity:
Cause: Denaturation, loss of essential cofactors, oxidation of critical residues
Solution: Include reducing agents, add potential cofactors, optimize buffer conditions
Validation of research findings for uncharacterized proteins like YAR047C requires multiple layers of confirmation:
Technical Validation:
Independent experimental replicates (minimum of three)
Use of appropriate positive and negative controls
Application of different methodological approaches to confirm findings
Biological Validation:
Complementary assays that approach the question from different angles
In vivo confirmation of in vitro findings
Genetic approaches (knockout/knockdown followed by complementation)
Use of structurally similar proteins as comparisons
Computational Validation:
Structure prediction tools to support experimental findings
Sequence analysis to identify conserved domains
Network analysis to place findings in biological context
The field of membrane protein research is rapidly evolving with several promising technologies:
Cryo-EM Advances:
Single-particle cryo-EM for structural determination without crystallization
Microcrystal electron diffraction (MicroED) for structural studies using smaller crystals
Native Mass Spectrometry:
Analyzing membrane proteins in near-native states
Characterizing protein-lipid interactions
Advanced Microscopy:
Super-resolution microscopy for visualizing protein arrangements in membranes
Correlative light and electron microscopy (CLEM) for multiscale imaging
Computational Approaches:
Improved membrane protein structure prediction algorithms
Molecular dynamics simulations with enhanced membrane modeling
Gene Editing Tools:
CRISPR-Cas9 for precise genomic tagging and functional studies
Base editors for studying specific amino acid contributions
Structural characterization of YAR047C would significantly enhance our understanding of this protein and potentially similar uncharacterized membrane proteins:
Structure determination could reveal:
Membrane topology and orientation
Presence of functional domains or motifs not evident from sequence alone
Potential binding sites for ligands or interaction partners
Conformational states that might suggest function
Comparative structural analysis could:
Identify structural similarities to functionally characterized proteins
Reveal evolutionary relationships not detected at sequence level
Suggest potential functions based on structural homology
Structure-guided experiments would enable:
Rational design of mutations to test functional hypotheses
Development of specific inhibitors or modulators
Prediction of interaction interfaces with other proteins